The North America HIV Injection Market would witness market growth of 16.9% CAGR during the forecast period (2023-2030).
The US market dominated the North America HIV Injection Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $905.8 Million by 2029. The Canada market is experiencing a CAGR of 19.6% during (2023 - 2030). Additionally, The Mexico market would exhibit a CAGR of 18.5% during (2023 - 2030).
HIV (Human Immunodeficiency Virus) is a pathogen that targets the immune system's CD4 cells (T cells), which are crucial for defending against infections. HIV reduces the number of CD4 cells in the body, increasing the risk of infection-related cancers and infections if left untreated. A progressive depletion of these cells by HIV may render the body incapable of combating infections and diseases.
HIV is transmitted through contact with specific bodily fluids from an infected individual, including blood, sperm, vaginal fluids, rectal fluids, and breast milk. Sexual contact without protection, sharing needles or syringes with an infected person, and transmission from mother to child during childbirth or breastfeeding are the most prevalent modes of HIV transmission.
A significant public health concern is the increasing prevalence of HIV in North America, especially in certain populations and geographic regions. An increasing prevalence of HIV is also being observed in Canada. The Government of Canada reports that with 1,472 new cases, representing an 11.3% increase, the national rate of new HIV diagnoses for 2021 stood at 3.8 per 100,000 population. Hence, all of these factors will aid in the market's growth.
Free Valuable Insights: The HIV Injection Market is Predict to reach USD 2.8 Billion by 2030, at a CAGR of 17.6%
Based on Distribution Channel, the market is segmented into Hospital Pharmacy, Drugs Stores & Retail Pharmacies, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
List of Key Companies Profiled
- GlaxoSmithKline PLC (GSK)
- Gilead Sciences, Inc.
- ImmunityBio, Inc.
- F.Hoffmann-La Roche Ltd.
- Theratechnologies Inc.
- Viriom, Inc.
- AbbVie, Inc.
- Brii Biosciences Limited
- Shionogi & Co., Ltd.
- Boehringer Ingelheim International GmbH
North America HIV Injection Market Report Segmentation
By Distribution Channel
- Hospital Pharmacy
- Drugs Stores & Retail Pharmacies
- Others
By Country
- US
- Canada
- Mexico
- Rest of North America
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America HIV Injection Market, by Distribution Channel
1.4.2 North America HIV Injection Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Opportunities
3.2.3 Market Restraints
3.2.4 Market Challenges
3.3 Porter’s Five Forces Analysis
Chapter 4. North America HIV Injection Market by Distribution Channel
4.1 North America Hospital Pharmacy Market by Country
4.2 North America Drugs Stores & Retail Pharmacies Market by Country
4.3 North America Others Market by Country
Chapter 5. North America HIV Injection Market by Country
5.1 US HIV Injection Market
5.1.1 US HIV Injection Market by Distribution Channel
5.2 Canada HIV Injection Market
5.2.1 Canada HIV Injection Market by Distribution Channel
5.3 Mexico HIV Injection Market
5.3.1 Mexico HIV Injection Market by Distribution Channel
5.4 Rest of North America HIV Injection Market
5.4.1 Rest of North America HIV Injection Market by Distribution Channel
Chapter 6. Company Profiles
6.1 GlaxoSmithKline PLC (GSK)
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Regional Analysis
6.1.4 Research & Development Expense
6.1.5 SWOT Analysis
6.1 Gilead Sciences, Inc.
6.1.1 Company overview
6.1.2 Financial Analysis
6.1.3 Research & Development Expenses
6.1.4 SWOT Analysis
6.2 ImmunityBio, Inc.
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Regional Analysis
6.2.4 Research & Development Expenses
6.2.5 SWOT Analysis
6.3 F. Hoffmann-La Roche Ltd.
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Segmental and Regional Analysis
6.3.4 Research & Development Expense
6.3.5 SWOT Analysis
6.4 Theratechnologies Inc.
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Research & Development Expenses
6.4.4 SWOT Analysis
6.5 Viriom, Inc.
6.5.1 Company Overview
6.5.2 SWOT Analysis
6.6 AbbVie, Inc.
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Regional Analysis
6.6.4 Research & Development Expense
6.6.5 SWOT Analysis
6.7 Brii Biosciences Limited
6.7.1 Company Overview
6.7.2 Financial Analysis
6.7.3 Research & Development Expenses
6.7.4 SWOT Analysis
6.8 Shionogi & Co., Ltd.
6.8.1 Company Overview
6.8.2 Financial Analysis
6.8.3 Research & Development Expenses
6.8.4 SWOT Analysis
6.9 Boehringer Ingelheim International GmbH
6.9.1 Company Overview
6.9.2 Financial Analysis
6.9.3 Regional & Segmental Analysis
6.9.4 Research & Development Expenses
6.9.5 SWOT Analysis
TABLE 1 North America HIV Injection Market, 2019 - 2022, USD Million
TABLE 2 North America HIV Injection Market, 2023 - 2030, USD Million
TABLE 3 North America HIV Injection Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 4 North America HIV Injection Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 5 North America Hospital Pharmacy Market by Country, 2019 - 2022, USD Million
TABLE 6 North America Hospital Pharmacy Market by Country, 2023 - 2030, USD Million
TABLE 7 North America Drugs Stores & Retail Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 8 North America Drugs Stores & Retail Pharmacies Market by Country, 2023 - 2030, USD Million
TABLE 9 North America Others Market by Country, 2019 - 2022, USD Million
TABLE 10 North America Others Market by Country, 2023 - 2030, USD Million
TABLE 11 North America HIV Injection Market by Country, 2019 - 2022, USD Million
TABLE 12 North America HIV Injection Market by Country, 2023 - 2030, USD Million
TABLE 13 US HIV Injection Market, 2019 - 2022, USD Million
TABLE 14 US HIV Injection Market, 2023 - 2030, USD Million
TABLE 15 US HIV Injection Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 16 US HIV Injection Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 17 Canada HIV Injection Market, 2019 - 2022, USD Million
TABLE 18 Canada HIV Injection Market, 2023 - 2030, USD Million
TABLE 19 Canada HIV Injection Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 20 Canada HIV Injection Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 21 Mexico HIV Injection Market, 2019 - 2022, USD Million
TABLE 22 Mexico HIV Injection Market, 2023 - 2030, USD Million
TABLE 23 Mexico HIV Injection Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 24 Mexico HIV Injection Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 25 Rest of North America HIV Injection Market, 2019 - 2022, USD Million
TABLE 26 Rest of North America HIV Injection Market, 2023 - 2030, USD Million
TABLE 27 Rest of North America HIV Injection Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 28 Rest of North America HIV Injection Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 29 Key Information – GlaxoSmithKline PLC
TABLE 30 Key Information – Gilead Sciences, Inc.
TABLE 31 Key Information – ImmunityBio, Inc.
TABLE 32 Key Information – F. Hoffmann-La Roche Ltd.
TABLE 33 Key Information – Theratechnologies Inc.
TABLE 34 Key Information – Viriom, Inc.
TABLE 35 Key information – AbbVie, Inc.
TABLE 36 Key Information – Brii Biosciences Limited
TABLE 37 Key Information – Shionogi & Co., Ltd.
TABLE 38 Key Information – Boehringer Ingelheim International GmbH
List of Figures
FIG 1 Methodology for the research
FIG 2 North America HIV Injection Market, 2019 - 2030, USD Million
FIG 3 Key Factors Impacting HIV Injection Market
FIG 4 Porter’s Five Forces Analysis - HIV Injection Market
FIG 5 North America HIV Injection Market share by Distribution Channel, 2022
FIG 6 North America HIV Injection Market share by Distribution Channel, 2030
FIG 7 North America HIV Injection Market by Distribution Channel, 2019 - 2030, USD Million
FIG 8 North America HIV Injection Market share by Country, 2022
FIG 9 North America HIV Injection Market share by Country, 2030
FIG 10 North America HIV Injection Market by Country, 2019 - 2030, USD Million
FIG 11 SWOT Analysis: GlaxoSmithKline PLC
FIG 12 SWOT Analysis: Gilead Sciences, Inc.
FIG 13 SWOT Analysis: ImmunityBio, Inc.
FIG 14 SWOT Analysis: F. Hoffmann-La Roche Ltd.
FIG 15 SWOT Analysis: Theratechnologies Inc.
FIG 16 SWOT Analysis: Viriom, Inc.
FIG 17 Swot Analysis: AbbVie, Inc.
FIG 18 SWOT Analysis: Brii Biosciences Limited
FIG 19 SWOT Analysis: Shionogi & Co., Ltd.
FIG 20 SWOT Analysis: Boehringer Ingelheim International GmbH